SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-023845
Filing Date
2021-09-27
Accepted
2021-09-27 16:05:53
Documents
17
Period of Report
2021-09-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44716
2 ex4-1.htm EX-4.1 166929
3 ex4-2.htm EX-4.2 84371
4 ex4-3.htm EX-4.3 85024
5 ex10-1.htm EX-10.1 183338
6 ex10-2.htm EX-10.2 122986
  Complete submission text file 0001493152-21-023845.txt   1003179

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE owpc-20210924.xsd EX-101.SCH 3042
8 XBRL LABEL FILE owpc-20210924_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE owpc-20210924_pre.xml EX-101.PRE 22370
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3296
Mailing Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118
Business Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118 7026050605
One World Pharma, Inc. (Filer) CIK: 0001622244 (see all company filings)

IRS No.: 611744826 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56151 | Film No.: 211281699
SIC: 2834 Pharmaceutical Preparations